↓ Skip to main content

Cochrane Database of Systematic Reviews

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, January 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
50 tweeters
facebook
6 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
135 Mendeley
citeulike
4 CiteULike
Title
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
Published in
Cochrane database of systematic reviews, January 2015
DOI 10.1002/14651858.cd008170.pub2
Pubmed ID
Authors

Hao Xue, Zhuang Lu, Wen Lu Tang, Lu Wei Pang, Gan Mi Wang, Gavin WK Wong, James M Wright

Twitter Demographics

The data shown below were collected from the profiles of 50 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
United States 1 <1%
Canada 1 <1%
Unknown 131 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 20%
Researcher 22 16%
Student > Bachelor 20 15%
Student > Postgraduate 10 7%
Student > Doctoral Student 10 7%
Other 27 20%
Unknown 19 14%
Readers by discipline Count As %
Medicine and Dentistry 77 57%
Nursing and Health Professions 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Agricultural and Biological Sciences 5 4%
Social Sciences 3 2%
Other 9 7%
Unknown 20 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2018.
All research outputs
#940,610
of 20,807,010 outputs
Outputs from Cochrane database of systematic reviews
#2,200
of 12,100 outputs
Outputs of similar age
#15,489
of 339,434 outputs
Outputs of similar age from Cochrane database of systematic reviews
#55
of 243 outputs
Altmetric has tracked 20,807,010 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,100 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,434 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 243 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.